Sharda Cropchem Limited delivered impressive financial performance in Q3FY26, demonstrating strong operational efficiency and market expansion across its global operations. The agrochemicals major reported substantial growth across key financial metrics, reinforcing its position in the international crop protection market.

Financial Performance Highlights

The company's consolidated financial results for Q3FY26 showcased remarkable growth momentum with comprehensive improvements across revenue and profitability parameters.

Nine Months Performance

For the nine months ended December 31, 2025, Sharda Cropchem maintained its strong performance trajectory with sustained growth across all major financial indicators.

Segment-wise Revenue Analysis

The company's business segments demonstrated varied performance patterns, with the core agrochemicals segment driving overall growth while maintaining diversification through non-agrochemicals operations.

Q3FY26 Segment Performance:

• Agrochemicals: ₹114,111.51 lakhs (vs ₹76,875.55 lakhs in Q3FY25)
• Non-agrochemicals: ₹14,764.23 lakhs (vs ₹16,057.03 lakhs in Q3FY25)

Nine Months FY26 Segment Performance:

• Agrochemicals: ₹279,009.17 lakhs (vs ₹208,219.71 lakhs in 9M FY25)
• Non-agrochemicals: ₹41,259.30 lakhs (vs ₹40,913.07 lakhs in 9M FY25)

Dividend Declaration and Corporate Actions

The Board of Directors approved an interim dividend distribution reflecting the company's strong cash generation and commitment to shareholder returns.

Operational Efficiency Metrics

The company demonstrated improved operational efficiency with better cost management and enhanced profitability margins. Total expenses for Q3FY26 stood at ₹113,143.76 lakhs compared to ₹88,401.10 lakhs in Q3FY25, while maintaining strong profit before tax at ₹17,856.22 lakhs against ₹4,593.09 lakhs in the previous year.

Global Operations Structure

Sharda Cropchem operates through an extensive network of 39 subsidiaries, including 11 step-down subsidiaries, spanning across multiple international markets. The company's global presence encompasses operations in Europe, Americas, Asia-Pacific, and Africa, positioning it as a significant player in the international agrochemicals market.

The management noted that the agrochemicals segment remains seasonal in nature, with performance influenced by cropping patterns and weather conditions globally. Quarterly figures may not be representative of full-year performance due to these seasonal variations.

Sharda Cropchem Limited has announced that its Board of Directors will meet on January 29, 2026, to review and approve the company's third-quarter financial performance for FY26. The meeting will focus on considering the unaudited financial results for both standalone and consolidated operations.

Board Meeting Agenda

The Board meeting has been scheduled to address several key corporate matters as outlined in the company's regulatory filing dated January 20, 2026.

Financial Results Review

The Board will consider, approve and take on record the unaudited financial results covering both standalone and consolidated operations for the quarter and nine months ended December 31, 2025. This review represents the company's third-quarter performance for the Financial Year 2025-26.

Dividend Consideration

As part of the meeting agenda, the Board will deliberate on declaring an interim dividend on the paid-up equity share capital of the company for Financial Year 2025-26. The final decision on dividend declaration will be made during the Board meeting.

Trading Window Closure

In compliance with SEBI regulations on insider trading prevention, Sharda Cropchem Limited has implemented a trading window closure for all designated employees and connected persons.

Regulatory Compliance

The announcement has been made in accordance with Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both the National Stock Exchange of India Limited and BSE Limited about the scheduled Board meeting and trading window closure.

The communication was signed by Jetkin Gudhka, Company Secretary and Compliance Officer, ensuring proper corporate governance and regulatory adherence in the disclosure process.